Yazar "Deymeer, Feza" için listeleme
-
Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)
Çebi, Merve; Durmuş, Hacer; Yılmaz, Vuslat; Yentür, Sibel Penbe; Aysal, Fikret; Oflazer, Zehra Piraye; Parman, Yeşim Gülşen; Deymeer, Feza; Saruhan-Direskeneli, Güher (Wiley, 2019)A small subset of myasthenia gravis (MG) patients develop autoantibodies against muscle-specific kinase (MuSK), which are predominantly of the immunoglobulin (Ig)G4 isotype. MuSK-MG is strongly associated with HLA-DRB1*14, ... -
Revisiting the complex architecture of ALS in Turkey: Expanding genotypes, shared phenotypes, molecular networks, and a public variant database
Tunca, Ceren; Şeker, Tuncay; Akçimen, Fulya; Coşkun, Cemre; Bayraktar, Elif; Palvadeau, Robin; Zor, Seyit; Koçoğlu, Cemile; Kartal, Ece; Şen, Nesli Ece; Hamzeiy, Hamid; Özoğuz Erimiş, Aslıhan; Norman, Utku; Karakahya, Oğuzhan; Olgun, Gülden; Akgün, Tahsin; Durmuş, Hacer; Şahin, Erdi; Çakar, Arman; Başar Gürsoy, Esra; Babacan Yıldız, Gülşen; İşak, Barış; Uluç, Kayıhan; Hanağası, Haşmet; Bilgiç, Başar; Turgut, Nilda; Aysal, Fikret; Ertaş, Mustafa; Boz, Cavit; Kotan, Dilcan; İdrisoğlu, Halil; Soysal, Aysun; Uzun Adatepe, Nurten; Akalın, Mehmet Ali; Koç, Filiz; Tan, Ersin; Oflazer, Piraye; Deymeer, Feza; Taştan, Öznur; Çiçek, Ercüment; Kavak, Ersen; Parman, Yeşim; Başak, Nazlı (Wiley, 2020)The last decade has proven that amyotrophic lateral sclerosis (ALS) is clinically and genetically heterogeneous, and that the genetic component in sporadic cases might be stronger than expected. This study investigates ... -
Turkish version of the motor function measure scale (MFM-32) for neuromuscular diseases: A cross-cultural adaptation, reliability, and validity study
İnal, Habibe Serap; Tarakçı, Ela; Tarakçı, Devrim; Aksoy, Gülcan; Mergen Kılıç, Sezan; Beşer, Hakan; Beşer, Çiğdem; Özdinçler, Arzu Razak; Durmuş Tekçe, Hacer; Parman, Fatma Yeşim; Deymeer, Feza; Oflazer, Zehra Piraye (TUBİTAK Scientific & Technical Research Council Turkey, 2017)Background/aim: The Motor Function Measure (MFM-32) is a classification system for ambulant and nonambulant patients with neuromuscular diseases (NMDs). We aimed to translate it into Turkish, culturally adapt it, and test ...